1. Home
  2. QNTM vs GMM Comparison

QNTM vs GMM Comparison

Compare QNTM & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • GMM
  • Stock Information
  • Founded
  • QNTM 1998
  • GMM 2017
  • Country
  • QNTM Canada
  • GMM China
  • Employees
  • QNTM N/A
  • GMM N/A
  • Industry
  • QNTM
  • GMM
  • Sector
  • QNTM
  • GMM
  • Exchange
  • QNTM NYSE
  • GMM Nasdaq
  • Market Cap
  • QNTM 9.1M
  • GMM 9.8M
  • IPO Year
  • QNTM N/A
  • GMM 2023
  • Fundamental
  • Price
  • QNTM $3.42
  • GMM $3.87
  • Analyst Decision
  • QNTM
  • GMM
  • Analyst Count
  • QNTM 0
  • GMM 0
  • Target Price
  • QNTM N/A
  • GMM N/A
  • AVG Volume (30 Days)
  • QNTM 223.5K
  • GMM 144.9K
  • Earning Date
  • QNTM 01-28-2025
  • GMM 01-29-2025
  • Dividend Yield
  • QNTM N/A
  • GMM N/A
  • EPS Growth
  • QNTM N/A
  • GMM 62.17
  • EPS
  • QNTM N/A
  • GMM 6.37
  • Revenue
  • QNTM N/A
  • GMM $41,360,953.00
  • Revenue This Year
  • QNTM N/A
  • GMM N/A
  • Revenue Next Year
  • QNTM N/A
  • GMM N/A
  • P/E Ratio
  • QNTM N/A
  • GMM $0.61
  • Revenue Growth
  • QNTM N/A
  • GMM 53.82
  • 52 Week Low
  • QNTM $2.70
  • GMM $0.21
  • 52 Week High
  • QNTM $70.85
  • GMM $4.97
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 41.28
  • GMM 54.98
  • Support Level
  • QNTM $3.20
  • GMM $3.55
  • Resistance Level
  • QNTM $3.55
  • GMM $4.16
  • Average True Range (ATR)
  • QNTM 0.43
  • GMM 0.58
  • MACD
  • QNTM -0.00
  • GMM -0.09
  • Stochastic Oscillator
  • QNTM 14.97
  • GMM 32.02

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd, formerly Global Mofy Metaverse Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: